Delivery of Radioiodine Ablation in a Patient with End-Stage Renal Disease

Abstract

This case presents a pragmatic approach to the management of a radioiodine remnant ablation patient on hemodialysis which required no pretherapeutic dosimetric measurements. Pretreatment radiation dose modeling was performed using literature values for radioiodine hemodialysis extraction efficacies to determine a safe treatment regimen including adjustment of the administered activity and hemodialysis frequency. The pretreatment modeling was subsequently verified using external and blood radiation monitoring during treatment.

Keywords

thyroid carcinoma - I-131 - hemodialysis - end-stage renal disease

• References

• 1 Lassmann M, Hänscheid H, Chiesa C, Hindorf C, Flux G, Luster M. EANM Dosimetry Committee. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy. Eur J Nucl Med Mol Imaging 2008; 35 (07) 1405-1412
• 2 Bussey A, Richardson M, Baker A. External dose-rate modelling of RRA radioiodine patients. Nucl Med Commun 2019;40(4):393–453
• 3 Vermandel M, Debruyne P, Beron A. et al. Management of patients with renal failure undergoing dialysis during ¹³¹I therapy for thyroid cancer. J Nucl Med 2020; 61 (08) 1161-1170
• 4 Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329 (14) 1001-1006
• 5 Held PJ, Port FK, Wolfe RA. et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50 (02) 550-556
• 6 Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305 (20) 1176-1181
• 7 Depner TA. Daily hemodialysis efficiency: an analysis of solute kinetics. Adv Ren Replace Ther 2001; 8 (04) 227-235
• 8 Suri RS, Nesrallah GE, Mainra R. et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 2006; 1 (01) 33-42
• 9 Piruzan E, Haghighatafshar M, Faghihi R, Entezarmahdi SM. Calculation of blood dose in patients treated with 131I using MIRD, imaging, and blood sampling methods. Medicine (Baltimore) 2016; 95 (11) e3154
• 10 Loevinger R, Budinger TF, Watson EE. 1988. MIRD Primer for Absorbed Dose Calculations. New York, NY: Society of Nuclear Medicine;